Measurement of monocyte activation:: application in the investigation of diabetic patients.

被引:0
|
作者
Nguyên, P [1 ]
Broussas, M [1 ]
Bertin, E [1 ]
Simon, G [1 ]
Hézard, N [1 ]
Potron, G [1 ]
机构
[1] CHU Robert Debre, Serv Diabetol, Cent Hematol Lab, F-51092 Reims, France
关键词
diabetes; vascular disease; tissue factor; monocyte; flow cytometry;
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Monocytes play a pivotal role in the complex processes of inflammation, immunologic responses and atherothrombosis. Clinical studies essentially reported an increased procoagulant activity in diabetes and coronary disease, suggesting an overexpression of tissue factor. This was further confirmed by the direct measurement of tissue factor on monocyte membrane by flow cytometry. Many receptors can bs measured on monocytes by flow cytometry: beta 2 integrins (CD11a-b-c/CD18) involved in adhesion, EPR-1 receptor, receptors for advanced glycation products, urokinase receptor U-PAR. Flow cytometry allows a cell analysis in whole blood. Modern methods allow a standardization of the procedures and a quantification of the number of sites expressed by the cell. However, the respect of preanalytical and analytical conditions is mandatory to obtain reliable data. Besides, clinical studies in diabetes should carefully define the subgroups of patients: type of diabetes, metabolic abnormalities, risk factors, infective complications (J Mal Vase 1999: 24: 275-280).
引用
收藏
页码:275 / 280
页数:6
相关论文
共 50 条
  • [41] Arterial Hypertension and Orthostatic Hypotension in Diabetic Patients.
    Gaspar, Ludovit
    Filipova, Slavomira
    Bendzala, Matej
    Gasparova, Iveta
    HYPERTENSION, 2017, 70
  • [42] Reduced platelet volume in microalbuminuric diabetic patients.
    Sayinalp, S
    Sayinalp, N
    BLOOD, 1999, 94 (10) : 84B - 84B
  • [43] Contribution of hypertension to vascular risk in diabetic patients.
    Marre, M
    Bouhanick, B
    Hadjadj, S
    Weekers, L
    DIABETES & METABOLISM, 1999, 25 : 27 - 31
  • [44] Periodontal pathogens and NO in crevicular fluid of diabetic patients.
    Skaleric, U
    Gaspirc, B
    McCartney, F
    Wahl, SM
    JOURNAL OF DENTAL RESEARCH, 2002, 81 : A126 - A126
  • [45] Frequency, characteristics and evolution of hypertension in diabetic patients.
    Blouza, S
    Abid, A
    Hamdi, W
    Kheder, I
    Nagati, K
    DIABETOLOGIA, 1997, 40 : 1766 - 1766
  • [46] Ionic variations in salivas from diabetic patients.
    Vargas, C
    Salas, M
    Schallmach, J
    Lopez, ME
    Chervonagura, A
    JOURNAL OF DENTAL RESEARCH, 1997, 76 (05) : 927 - 927
  • [47] Heart protection study: a focus on diabetic patients.
    Ogrin C.
    Perkelvald A.
    Winer N.
    Current Diabetes Reports, 2004, 4 (3) : 185 - 186
  • [48] Familial clustering of diabetic nephropathy in NIDDM patients.
    Canani, L
    Gerchman, F
    Gross, J
    DIABETES, 1997, 46 : 275 - 275
  • [49] Bone regeneration in diabetic patients. A systematic review
    Sabado-Bundo, Helena
    Angeles Sanchez-Garces, Ma
    Gay-Escoda, Cosme
    MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL, 2019, 24 (04): : E425 - E432
  • [50] Urinary heparan sulfate in normoalbuminuric diabetic patients.
    Bonavita, CD
    Elbert, A
    Paglione, AM
    Bragagnolo, J
    Mainetti, H
    Ruiz, M
    DIABETOLOGIA, 1997, 40 : 2017 - 2017